| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Clinical Chemist |
 |
AACC Award Winners, 1999 |
|---|
 Top AACC Award Winners, 1999 |
|---|
Dr. Bowie was born on April 23, 1944, in Vicksburg, Mississippi, where he was raised and obtained his education through high school. In 1966, he completed his BS at Xavier University in New Orleans with a specialization in medical technology. He was a part-time graduate student at Howard University Medical School in Washington, DC before starting on a doctoral program at Johns Hopkins University in Baltimore. Dr. Bowie obtained his PhD in biochemistry in 1972 with research investigations on bioluminescence.
At the University of California, San Diego, and the Veterans Administration (VA) Medical Center, Dr. Bowie joined Dr. Gochman as a postdoctoral trainee in clinical chemistry. He participated in all phases of academic clinical chemistry, including laboratory management, teaching, and research, and was clearly destined to be an outstanding figure in the profession. He quickly became an Assistant Adjunct Professor of Chemistry and Pathology at the University of California, San Diego, and Assistant Chief of the Clinical Chemistry Section at the VA Medical Center. Dr. Bowie was interested in hemoglobinopathies and received grant support for research and training in this field. He started his AACC participation with the Southern California Section of the AACC, holding several positions, and was a founder of the San Diego Section. During Dr. Gochman's year as AACC President, Dr. Bowie was an immense help in managing the clinical chemistry laboratory and was presented with a Presidential Citation Award at the 1978 Annual Meeting. This was to be the first of many honors and awards that would be conferred on Dr. Bowie during his exemplary career.
In 1979, Dr. Bowie became Director of the Division of Clinical Biochemistry at Evanston Hospital and Assistant Professor of Clinical Pathology at the Northwestern University Medical School. He intensified his research efforts on hemoglobinopathies and thalassemias, becoming a recognized authority in this area. In 1982, he discovered a previously undocumented abnormal hemoglobin and named it Hemoglobin Evanston. Dr. Bowie was an articulate and impressive speaker and was invited to lecture on various scientific topics throughout the US and other countries. He progressed through the academic ranks, reaching Professor of Pathology at Northwestern in 1992, and served as a Faculty Advisor in the Biotechnology Graduate Program. His duties at Evanston Hospital expanded, and by 1995, Dr. Bowie was Associate Chairman of the Department of Pathology and Laboratory Medicine, Director of Clinical Laboratories, and Director of the Division of Clinical Pathology.
Dr. Bowie's participation in all facets of the Chicago Section of the AACC, including Chairman, brought additional recognition to his motivational and leadership skills. He was elected as President of the AACC for 1993 and served with distinction. He served several other professional organizations during his career, including as a member of the Board of Directors of the National Academy of Clinical Biochemistry and Vice-President and Chair, Credentials Committee, of the American Board of Clinical Chemistry.
Somehow Dr. Bowie also found time to serve the US government in several capacities, including as a Member of the Food and Drug Administration Clinical Chemistry Advisory Panel and the Clinical Laboratory Improvement Advisory Committee (CLIAC) of the CDC.
Dr. Bowie received the 1985 Samuel Natelson Award and the 1980 Albert Dietz Award of the Chicago Section, AACC. The New Jersey Section of the AACC presented him with the Bernard Gerulat Award in 1993. Before his death, Lem was Chair of the AACC Awards Committee and had recently been appointed to the Board of Editors of Clinical Chemistry.
This brief recounting of Dr. Bowie's accomplishments cannot do justice to this outstandingly warm and friendly scientist-educator. The profession of clinical chemistry, his colleagues, his friends, and most of all, his family, will mourn the absence of this gifted, talented, and winning personality.
AACC Award for Outstanding Contributions through Service to the
Profession of Clinical Chemistry
Jean C. Joseph,
PhD, will receive the 34th annual award, sponsored by Beckman
Instruments, Inc. Dr. Joseph is Chief Operating Officer for CDT, Inc.
(Comprehensive Drug Testing) located in Long Beach, California. CDT
administers drug and alcohol programs for many professional sports
organizations and for clients from the transportation industry,
schools, and the public and private sectors. Dr. Joseph was raised in
the Boston, Massachusetts area; she graduated from Archbishop William
High School in Braintree and received her BA degree in Chemistry from
Regis College in Weston, Massachusetts.
Dr. Joseph received a PhD in Biological Chemistry from the University of Illinois Medical Center, Chicago, Illinois. After working 2 years in research, she completed a postdoctoral fellowship in Clinical Chemistry at Loyola University Medical Center in Maywood, Illinois. Dr. Joseph received a Masters in Health Administration from Chapman University in 1990. She is board certified in both Clinical Chemistry and Toxicological Chemistry by the American Board of Clinical Chemistry and is licensed by the State of California as a Clinical Chemist. Dr. Joseph has lectured and published in the fields of chemistry, toxicology, and management.
Prior to assuming her present duties, Dr. Joseph worked in the laboratory and physician practice management fields. Her first position was as Assistant Director of Biochemistry at Michael Reese Hospital and Medical Center in Chicago, Illinois. Dr. Joseph then served as Director of Chemistry and Assistant Director of Laboratories at St. Mary Medical Center in Long Beach, California. She next held the position of Manager of Physician Practice and Clinic Services at Argus Medical Management in Long Beach, California.
Dr. Joseph has been active with the AACC since becoming a member in 1977. On the local section level, she was active in the Chicago Section, and as a member of the Southern California Section has served as Treasurer, Program Chair, Councilor/Delegate, and Chair.
On the national level, Dr. Joseph served as member of the 1982 National Meeting Organizing Committee, as Vice-Chair of the 1997 Annual Meeting Organizing Committee, and is presently a member of the 2000 Annual Meeting Organizing Committee. In addition, Dr. Joseph has served as member and Chair of the Continuing Education Committee, member of the Council Committee on Divisional Affairs, member of the Council Steering Committee, and member of the Long Range Planning Committee. She was elected as member and Chair of the Nominating Committee (1988–1989) and was a member of the Quality Assurance Committee, a member of the Quality Assurance Task Force, Co-Chair of the Local Section Workshop, Chair of the House of Delegates Local Section Affairs Committee, and a member of the Editorial Advisory Board to Clinical Chemistry News. Dr. Joseph was a member of the Board of Directors from 1993 to 1995 and served on the Board of Directors Executive Committee. She was a member of the GPO and Purchasing Executive Conference Committees, a member of the Delta Group (1995–1996), a member of the Task Force on Governance (1997), and is presently serving on the Program Coordinating Commission. Dr. Joseph was the recipient of an AACC Presidential Citation in 1996 and the recipient of the Herbert O. Carne Service Award presented by the Southern California Section.
In addition to her activities with the AACC, Dr. Joseph has been active with the American Board of Clinical Chemistry (ABCC), the National Committee on Clinical Laboratory Standards (NCCLS), and the National Academy of Clinical Biochemistry (NACB). Dr. Joseph was a member of the Board of Directors of the ABCC from 1990 to 1996, serving as Secretary-Treasurer in 1993–1994 and as President in 1994–1995. She also served as a member of the NCCLS Area Committee on Clinical Chemistry and Toxicology. Dr. Joseph presently is a member of the Board of Directors of the NACB. In addition, Dr. Joseph is a member of the American College of Healthcare Executives and Women in Health Administration.
AACC Award for Outstanding Contributions in Education
D. Robert Dufour,
MD, will receive the 29th annual award, sponsored by SmithKline
Beecham Clinical Laboratories. D. Robert Dufour, MD, DABP, is Chief of
Pathology and Laboratory Medicine Service, VA Medical Center,
Washington, DC; he is also Professor of Pathology at George Washington
University Medical Center and Clinical Professor of Pathology,
Uniformed Services University of the Health Sciences. A native of
Milwaukee, Wisconsin, Dr. Dufour received an Honors BS in Chemistry
from Marquette University in 1971 and an MD from the Medical College of
Wisconsin in 1975. He completed residency training in Pathology at the
National Naval Medical Center in 1979. He was Head of Clinical
Chemistry at the Naval Regional Medical Center in Portsmouth, Virginia,
from 1979 to 1982, and then became Assistant Professor of Pathology and
Pathology Course Director at the Uniformed Services University of the
Health Sciences. He became Head of Clinical Chemistry at the VA in
Washington in 1985 before assuming his current position in 1992. Dr.
Dufour was certified by the American Board of Pathology in Anatomic and
Clinical Pathology in 1980 and in Chemical Pathology in 1984. He is a
Fellow of the National Academy of Clinical Biochemistry, the College of
American Pathologists, and the American Society for Clinical Pathology.
Dr. Dufour has been active in educational programs since early in his career. He has taught on the faculty of four medical schools (and currently lectures at three) and frequently is invited to speak on laboratory topics in the Washington metropolitan area. He has developed two computer-assisted software programs for teaching medical students the cost-effective use of laboratory tests. He is the main faculty member responsible for training in Clinical Chemistry for three different residency programs (George Washington, Georgetown, and Capitol Military Consortium) and frequently is a preceptor for internal medicine residents, medical students, and externs doing electives in Clinical Chemistry; he also trains Endocrinology fellows in endocrine laboratory tests. He has trained more than 100 pathology residents, 25 endocrine fellows, 25 internal medicine residents, and 20 medical students and externs in Clinical Chemistry. He has been widely recognized for his teaching abilities; he has received 13 Golden Apple awards at the Uniformed Services University of the Health Sciences and has received that school's two highest teaching awards: the Outstanding Military Faculty and Outstanding Civilian Faculty awards. At George Washington, he has been selected as Medical School Basic Science faculty of the year and Pathology Department faculty of the year. He also is frequently recognized as an AACC Outstanding Speaker.
A member of AACC since 1984, Dr. Dufour has been involved in many aspects of education in the organization. A member of the Continuing Education Committee from 1992 to 1996, he was Chair of the Committee for 3 years and oversaw the reinvention of the ACCENT program, developing educational standards for all programs and organization-wide needs assessment, as well as providing training on educational design to local section and division leadership. He was involved in AACC's initial application to be a continuing medical education provider and chaired the Continuing Medical Education Advisory Committee for its first 4 years, leading to full CME accreditation. He has been co-director of the Clinical Chemistry review course since its inception in 1990, the only faculty member to teach in every course offered, and was a member of the review course committee from 1990 to 1998. He currently is Chair of the Training Course Committee. He is also Chair of the National Academy of Clinical Biochemistry's Education and Scientific Affairs Committee. He has served on many other AACC committees, including currently serving on the Delta Program, Meetings Management Group, the Patient Education Task Force, as Past-Chair of the Capitol Section, and as a member of the House of Delegates.
A resident of Potomac, Maryland, Dr. Dufour is married to Mary C. Dufour, MD, MPH; they have four children: Brian 22, Libby 19, Andrew 18, and Robert 16.
AACC Award for Outstanding Contributions to Clinical Chemistry in a
Selected Area of Research
Eleftherios P. Diamandis, MD,
PhD, will receive the 27th annual award, sponsored by the Roche
Diagnostic Systems. Dr. Diamandis currently is Head, Section of
Clinical Biochemistry, Department of Pathology and Laboratory Medicine,
Mount Sinai Hospital, Toronto, and Professor and Head, Division of
Clinical Biochemistry, Department of Laboratory Medicine and
Pathobiology, University of Toronto. He received his BS in Chemistry,
his PhD in Analytical Chemistry, and his Medical Degree from the
University of Athens, Greece. He completed a Post-Doctoral Diploma
Program at the Department of Clinical Biochemistry, University of
Toronto. Dr. Diamandis is board certified in Clinical Chemistry by the
Canadian Academy of Clinical Biochemistry and the American Board of
Clinical Chemistry and is a Fellow of the Royal College of Physicians
of Canada (FRCPC).
Dr. Diamandis has played an active role in the AACC for many years and is currently a member of the Organizing Committee of the Oak Ridge Conference.
His research interests include advanced analytical technology and instrumentation, especially the technique of time-resolved fluorometry and its applications for developing highly sensitive immunological and molecular techniques. He is also interested in designing new methodologies for the diagnosis and monitoring of breast, prostate, and other cancers and in the identification of new genes that are involved in various cancers. Over the last 5 years, Dr. Diamandis published extensively on prostate-specific antigen and its use in prostate and breast cancer diagnostics. More recently, his group has identified a number of novel genes that belong to the kallikrein gene family and molecularly characterized the kallikrein gene locus in humans. Previously, he published extensively on the p53 tumor suppressor and its role in carcinogenesis as well as its clinical applications.
Dr. Diamandis has presented to numerous national and international meetings and has published more than 250 research papers, review articles, and book chapters. He co-edited a book entitled Immunoassay, published by Academic Press in 1996.
Dr. Diamandis' previous awards and honors include the Chisholm Memorial Fellowship from the University of Toronto (1983), the AACC Award for Outstanding Scientific Achievements by a Young Investigator (1985), the Med-Chem Laboratories Award for Best Poster Presentations at the annual Canadian Society of Clinical Chemists meeting (co-author of eight different winning posters between 1985 and 1998), the Van Slyke Society Research Grant Award of the AACC (1989), the annual Research Excellence Award of the Canadian Society of Clinical Chemists (1995), and the Excellence in Teaching Award from the Department of Clinical Biochemistry, University of Toronto (1997). He was "Kubasik Lecturer", Upstate New York Section of the AACC (1998), and has won the Distinguished Scientist Award of the Clinical Ligand Assay Society (1999).
AACC Award for Outstanding Scientific Achievements by a Young
Investigator
Elizabeth Rohlfs,
PhD, will receive the 24th annual award, sponsored by Boehringer
Mannheim Corp. Dr. Rohlfs is the Associate Director of the Molecular
Genetics Laboratory at The University of North Carolina Hospitals and
Clinical Assistant Professor in the Department of Pathology and
Laboratory Medicine at the University of North Carolina at Chapel Hill.
Dr. Rohlfs received her BA cum laude from Connecticut College where she majored in Zoology. She received her PhD in Pathology from Boston University under the direction of Dr. Steven Zeisel; during her time at Boston University, she was awarded a Boston University Graduate Student Research Award (1990). For her doctoral dissertation, Dr. Rohlfs studied the signal transduction pathways involved in lipid and protein secretion from breast epithelial cells. Dr. Rohlfs completed a postdoctoral fellowship at Duke University under the direction of Dr. Sheila Collins in the area of molecular pharmacology. While at Duke, she studied the regulation of uncoupling protein gene expression by stimulation of ß-adrenergic receptors in brown adipose tissue. From there, Dr. Rohlfs entered the Clinical Chemistry fellowship program at the University of North Carolina (UNC) and began work with Dr. John Chapman, conducting an analytical and clinical evaluation of refractive index-matched anomalous diffraction (RIMAD) and its ability to predict fetal lung maturity. In the second year of her Clinical Chemistry fellowship, she was accepted into the American Board of Medical Genetics certified Clinical Molecular Genetics training program at UNC. Under the direction of Dr. Lawrence Silverman, Dr. Rohlfs developed and evaluated protein truncation analysis and allele-specific assays for the detection of disease-causing mutations in the breast and ovarian cancer genes, BRCA1 and BRCA2. Because of this work, breast cancer susceptibility testing is now offered at UNC as part of the Multidisciplinary Breast Clinic.
As Associate Director of the Molecular Genetics Laboratory, Dr. Rohlfs continues to supervise the clinical testing and development of other cancer genetics testing. She also has an active research project investigating genetic mechanisms that produce mutations in BRCA1 in both high-risk families and in population-based cases of breast cancer. This has led to the identification of novel homologous recombination events in BRCA1 that produce large genomic rearrangements, which account for a significant proportion of the mutation spectrum in BRCA1. For her work in this area of breast cancer research, Dr. Rohlfs has received the AACC Student Research Award (1996), the Paul E. Strandjord Young Investigator Award from the Academy of Clinical Laboratory Physicians and Scientists (1996), a Junior Faculty Development Award from UNC (1997), and the AACC Van Slyke Research Award (1998). Dr. Rohlfs has given presentations at local and national meetings and has numerous peer-reviewed publications and co-authored book chapters. She is an active member of the AACC and a member of the Molecular Pathology Division.
AACC International Travel Fellowship
Gábor L. Kovács, MD,
PhD, will receive the 21st annual award, sponsored by Becton
Dickinson Vacutainer Systems, Becton Dickinson and Co. Gábor L.
Kovács was born in Pécs (Hungary) on March 15th, 1948. He
finished primary and secondary school in Pécs. Between 1966 and
1972, he studied medicine at the University Medical School in
Pécs, where he received a medical degree summa cum laude in 1972.
He joined the neuroendocrine research group in the Institute of
Physiology in Pécs, where he became involved in research projects
investigating the interactions of neuronal peptides, adrenal steroids,
and the central nervous system's adaptation processes. In 1975, he
specialized in laboratory medicine and clinical chemistry. In 1976, he
moved to the Institute of Pathophysiology of the Albert
Szent-Györgyi Medical University in Szeged, Hungary. In 1977 and
1978, he worked on posterior pituitary and opioid peptides at the
Rudolf Magnus Institute, University of Utrecht, The Netherlands. He
defended his PhD dissertation on the interaction of posterior pituitary
hormones, adrenal steroids, and adaptation in 1979.
Dr. Kovács has been an invited speaker at various international conferences and seminars in the US, Japan, Italy, Germany, The Netherlands, Ireland, France, Switzerland, Sweden, and other countries on several occasions. He has published 55 book chapters and 125 original publications in various international journals. In 1986, he defended his Doctor of Sciences (DSci) thesis at the Hungarian Academy of Sciences, on the role of neuronal peptides in neuronal adaptive processes during drug addiction.
In 1987, Dr. Kovács was appointed as laboratory director at the Markusovszky Teaching Hospital in Szombathely. This tertiary care hospital—one of the largest hospitals in Hungary, with more than 1500 patient beds—is the teaching hospital of the University Medical School in Pécs as well as of the Imre Haynal Health Science University in Budapest. In 1990, soon after the transition in Eastern Europe, Dr. Kovács was elected medical director of the teaching hospital. He currently holds both positions. Between 1992 and 1995, he studied modern healthcare management at the University of Economy in Budapest and was actively involved in management programs for Eastern Europe of Project Hope (USA). In 1990, he received the title of Extraordinary Professor from the Albert Szent-Györgyi Medical University in Szeged, and in 1997, the University Medical School in Pécs nominated him as appointed professor.
Since 1987, Dr. Kovács has been actively involved in reorganization of laboratory sciences and service, implementation of modern technologies, and quality management in Hungary. Between 1992 and 1998, he was the Chairman of the Hungarian Board of Clinical Pathologists. During this period, a national not-for-profit external quality-control organization was founded, quality manuals were made mandatory, and colleges for laboratory technologists were set up in Hungary. In 1997, he was elected for a 4-year term as President of the Hungarian Society of Clinical Pathology. Since 1993, he has been a consulting (nonvoting) member of the Medical Division of Hungarian Academy of Sciences, where he was elected as Chairman of the Scientific Committee for Diagnostics in 1998. Since 1998, he has been a "doctor representative" of the General Assembly of Hungarian Academy of Sciences.
As a member of the Medical Division of Hungarian Accreditation Committee and the National Scientific Council in Medicine, he has been involved in regulatory matters of Hungarian healthcare and higher education. In 1999, he was elected as member of the Senate of the Teacher Training College in Szombathely.
Dr. Kovács has been actively participating in the international affairs of Hungarian laboratory sciences. He was one of the initiators of the regional "Alps-Adria Conferences" on laboratory medicine with the involvement of Austrian, Czech, Slovenian, Croatian, Italian, German, and Hungarian professional laboratory societies. Currently, he is the representative of the Hungarian Society of Clinical Pathology to IFCC. He is also member of AACC and of the New York Academy of Sciences.
In recognition of his activities, Dr. Kovács has received the Pandy Award of the Hungarian Society of Clinical Pathology (1992), Szechenyi professorship (1997), honorary membership in the Rumanian Society of Laboratory Medicine (1997), honorary membership in the Hungarian Society of Laboratory Technologists (1998), and the "Order of Hungarian Republic: Small Cross" (1998).
The AACC Lectureship Award
Charles H. Hennekens,
MD, will receive this year's award, supported by an educational
grant from Bayer Diagnostics. Dr. Hennekens received his MD from
Cornell University Medical College and completed a residency in
internal medicine from the New York Hospital-Cornell Medical Center. He
has a MPH, a MS, and a DrPH from the Harvard School of Public
Health, and honorary Doctor of Science degrees from the University of
Medicine and Dentistry of New Jersey and Queens College. He is or has
been the Eugene Braunwald Professor of Medicine, the John Snow
Professor of Medicine, and Professor of Ambulatory Care and Prevention
(all at Harvard Medical School) and Professor of Epidemiology at
Harvard School of Public Health, as well as Chief of the Division of
Preventive Medicine at Brigham and Women's Hospital.
Dr. Hennekens' research concerns the epidemiology of acute and chronic diseases, in particular, cardiovascular disease and cancer. He is the Principal or Co-Principal Investigator for the four long-term studies: the Physicians' Health Study, the Women's Health Study, the cardiovascular component of the Nurses' Health Study, and the Vanguard Center for the Women's Health Initiative. In addition, Dr. Hennekens serves as US National Coordinator for the International Studies of Infarct Survival. He has elucidated a number of causal, preventative, and therapeutic factors, most notably low-dose aspirin in cardiovascular disease.
Dr. Hennekens is President of the American Epidemiological Society and Past-President of the Society for Epidemiologic Research, as well as a member of the Association of American Physicians. He had been Editor-in-Chief of the American Journal of Preventative Medicine and Founding Editor-in-Chief of the Annals of Epidemiology. He has been a member of the Board of Overseers of the American Journal of Epidemiology as well as the editorial board of Circulation.
Dr. Hennekens is co-author of 528 publications, including 405 original reports, 120 reviews and book chapters, and 3 textbooks, including Epidemiology in Medicine, which is used widely in medical schools and schools of public health in the United States and abroad. He is a diplomate of the National Board of Medical Examiners and the American Board of Preventive Medicine and a Fellow of the American College of Preventive Medicine, as well as the American College of Epidemiology. He is the recipient of the Bruce Award from the American College of Physicians for distinguished contributions to preventive medicine, the VERIS Award for outstanding contributions to antioxidant vitamin research, an Honorary Fellowship from the American College of Cardiology for distinguished contributions to the field of cardiovascular medicine, the Lilienfeld Award from the American College of Epidemiology for excellence in the field of epidemiology, the first Robert S. Gordon Jr. Lectureship from the National Institutes of Health for significant contributions to epidemiology and clinical trials, the Duncan Clark Award from the American Teachers of Preventive Medicine for excellence in teaching and research in preventive medicine, the 1996 American College of Nutrition Award for outstanding contributions, the American Heart Association Lewis A. Conner Lectureship, and the International Society of Heart Failure Jan J. Kellerman Memorial Award for distinguished contributions to cardiovascular disease prevention.
AACC's Past President's Award
Stephen E. Kahn,
PhD, will receive this year's award, sponsored by the Allegiance
Healthcare Corporation. Stephen E. Kahn, PhD, DABCC, FACB, is presently
Director of Chemistry, Toxicology, and Near Patient Testing, and a
tenured Associate Professor of Pathology as well as Molecular and
Cellular Biochemistry at Loyola University Medical Center (LUMC) in
Maywood, Illinois. Dr. Kahn received a BS degree in Zoology from
Michigan State University in 1972 and his PhD in Biological Chemistry
from the University of Illinois Medical Center in 1978. At LUMC, he
completed postdoctoral training in clinical chemistry and in 1980,
joined the Section of Clinical Chemistry as a faculty member. He became
a certified diplomate of the American Board of Clinical Chemistry in
1982.
An AACC member since 1979, Dr. Kahn has held numerous positions within the association at the national and local levels. A member of AACC's Board of Directors (BOD), Dr. Kahn presently is the immediate Past President, having served as AACC's 49th President in 1998. Currently, he chairs the TnI Subcommittee and the Executive Management Team of Clinical Chemistry and serves as Vice-Chair of the 2000 Annual Meeting Organizing Committee (AMOC). Among his past AACC responsibilities, Dr. Kahn chaired the 1996 AMOC, the House of Delegates, the Commission on Education and Scientific Affairs, the Laboratory Improvement Program Management Group, the Joint AACC/CAP Steering Committee, and the Proficiency Testing Task Force. He is in his third term as a member of the Finance Committee. He also served as the 1986 AMOC Secretary, the 1992 AMOC Symposia Chair, as a member of the Task Force on the Changing Practice Environment, a member of the Strategic Analysis Task Force, and as Chair of the Task Group on CCJ Operations. In the Chicago Section, Dr. Kahn has held many positions, including Section Chair and Program Chair. For 6 years, he also served as the section's Delegate. In 1987, he was awarded the section's Albert A. Dietz Award for outstanding contributions in service, and in 1995, he was awarded the section's Samuel L. Natelson Award for outstanding contributions as a senior investigator. Dr. Kahn is a member of the Critical Care Testing, Point of Care, and TDM/Toxicology Divisions.
Dr. Kahn is very committed to education and has more than 80 publications. He teaches extensively on many subjects, having given numerous lectures throughout the country. His current areas of interest are protein markers of tissue injury, laboratory utilization, toxicology, and critical care testing. Dr. Kahn is a member of the Board of Directors of the American Board of Clinical Chemistry (ABCC) and has served as the ABCC's Secretary-Treasurer. He is also the Chair of the Nominating Committee of the National Academy of Clinical Biochemistry (NACB). Other selected activities include being a fellow of the Association of Clinical Laboratory Scientists, a fellow of NACB, an advisor to the HCFA Medical Review Panel, which developed the ICD-10-PCS system, a former member of the Chicagoland CLMA Board of Directors, an invited reviewer for several journals (including Clinical Chemistry and the Archives of Pathology and Laboratory Medicine), and an observer to the NCCLS Electrolyte Subcommittee.
Second Edwin F. Ullman Award to Norman G. Anderson
Norman G. Anderson received the second annual Edwin F.
Ullman Award at AACC's Oak Ridge Conference on April 23, 1999, in San
Jose, California. The award, sponsored by Dade Behring, Inc., was
established to recognize outstanding contributions that advance the
technology of clinical laboratory science. In conjunction with
receiving the award, Dr. Anderson made a presentation entitled
"Emerging Infectious Diseases: New Challenges for Clinical
Chemistry".
Dr. Anderson is currently chairman and chief scientist of Large Scale Biology Corporation in Rockville, Maryland. He is well known for the development of centrifugal clinical analyzers and centrifuges for vaccine purification. He worked at the Oak Ridge National Laboratory for 21 years, where he invented the zonal ultracentrifuge for subcellular fractionation and organized a joint National Institutes of Health and Atomic Energy Commission program to develop methods for the isolation of oncogenic viruses. This work led to the development of the large K series vaccine centrifuges still in use for large-scale virus production and vaccine purification. In 1968, he invented the first computer-controlled clinical analyzer. His methods for centrifugal analyzers appeared regularly in Clinical Chemistry for over a decade.
In 1976, he and his son, Dr. Leigh Anderson, moved to the Argonne National Laboratory where they collaborated to develop the Iso-Dalt system for high resolution two-dimensional electrophoresis and to apply it to clinical chemistry. Examples of this system have appeared in Clinical Chemistry.
In 1980, the Andersons proposed the Human Protein Index as a major bioscience project and enlarged on the idea in 1983 by writing the first proposal for the Human Genome Project.
In 1986, with associates from Argonne, they formed the Large Scale Biology Corporation to apply high-resolution quantitative protein mapping to the study of disease processes and drug effects. These studies have been fundamental to the emerging field of proteomics, which now includes high-resolution electrophoresis, mass spectrometric protein identification, high-resolution cell fractionation, and computerized management of large databases. As an extension of his cell fractionation studies, Dr. Anderson currently is developing a new system for the rapid separation and identification of viruses in clinical samples.
Dr. Anderson holds 29 patents with two pending and has published more than 300 scientific papers.
The Edwin F. Ullman Award, which includes a plaque and a $5000 honorarium, was initiated by and is funded by Behring Diagnostics to honor Dr. Ullman and to recognize his contributions to that company and to the field of clinical chemistry. A pioneer in immunoassay technology who received more than 150 US patents, Dr. Ullman is most widely known for his development of the EMIT assay, an advance that revolutionized testing for abused and therapeutic drugs.
Meetings
Fifth European Conference, Quality [r]evolution in
clinical laboratories, October 11 and 12, 1999, Antwerp,
Belgium. Information: Dr. H.M.J. Goldschmidt, Department of
CKCJL, St. Elisabeth Hospital, Tilburg, The Netherlands.
Phone 31-13-5392693; fax 31-13-5352390; e-mail
H.M.J.Goldschmidt@ckchl-mb.nl.
37th IUPAC Congress and 27th GDCh General Meeting, August 14–19, 1999, Berlin, Germany. Information: Gesellschaft Deutscher Chemiker, IUPAC 99, PO Box 90 04 40, D-60444 Frankfurt am Main, Germany. Phone 49-69-7917 360 or 366; fax 49-69-7917 475; e-mail iupac_congress@gdch.de; Internet http://www.gdch.de.
|
|
|
|
|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
